Remove 2019 Remove Individual Remove Provider Remove Utilities
article thumbnail

Differences in primary care utilization by primary care availability in the first year of Virginia Medicaid Expansion [Health care disparities]

Annals of Family Medicine

Importantly, Virginia's Medicaid expansion reduced cost-related barriers to accessing care for over 700,000 individuals. Setting or Dataset: 2019-2020 Virginia Department of Medical Assistance Services database (demographic, enrollment, and claims data). Of these, 117,481 (57.2%) individuals had at least one primary care visit.

article thumbnail

National variation in ASCVD risk between Pooled Cohort Equations and PREVENT [Cardiovascular disease]

Annals of Family Medicine

Context In November 2023, the American Heart Association (AHA) released PREVENT, a new set of risk equations to calculate an individual's risk of atherosclerotic cardiovascular disease (ASCVD). Each individual was separated into clinically significant risk categories of <7.5%, 7.5-10%, Results 3,885 individuals met the criteria.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

FDA Law Blog

In June 2019, Pfizer sought an OIG advisory opinion to ensure that its proposal would not run afoul of federal law. The Court found that there is at best little utility in interpreting the AKS by reference to the BIS. The Medicare program would pay most of the remaining $225,000 in annual cost. Pfizer’s Petition to SCOTUS.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Moreover, center patients not only in discussions about individual decision-making but in constructing and drawing meaning from the research. Our esteemed publications should ensure that investigations that utilize racial variables follow these guidelines before being published. 2019 Jun 25;73(24):3234]. 2019;322(2):113-114.

Clinic 52
article thumbnail

Let’s Listen to Patients: FDA Releases Final Guidance on Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

FDA Law Blog

The Agency’s goal is demonstrated in its definition of patient engagement: “Patient engagement is defined as intentional, meaningful interactions with patients that provide opportunities for mutual learning, and effective collaborations.” .

article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. These narratives have vilified individuals who would benefit from comprehensive, person-centered substance use treatment, rather than incarceration and other adverse harms.

article thumbnail

Episode 232: Anti-Racism in Medicine Series – Episode 15 – Housing is Health: Racism and Homelessness – Clinician + Community Perspectives

The Clinical Problem Solvers

Dr. Kushel and Mr. Watts remind healthcare providers to speak out about the structural causes of homelessness. Push back against individual narratives that blame individuals for systemic injustice. Published April 5, 2019. January 18, 2019. Calac, Victor A. Push back against dehumanizing language. Rothstein, R.